Skip to content
Ashvattha Therapeutics
Ashvattha Therapeutics
  • About Us
    • Senior Management Team
    • Board of Directors
    • Clinical Advisory Board
  • Technology
  • Pipeline
    • Overview
    • Migaldendranib (MGB)
  • News
  • Resources
  • Careers
  • Contact
Ashvattha Therapeutics
  • About Us
    • Senior Management Team
    • Board of Directors
    • Clinical Advisory Board
  • Technology
  • Pipeline
    • Overview
    • Migaldendranib (MGB)
  • News
  • Resources
  • Careers
  • Contact

Resource Type: Publications

Clinical Radiosynthesis and Translation of [ 18F]OP-801: A Novel Radiotracer for Imaging Reactive Microglia and Macrophages

Targeted Nanomedicine: Ashvattha Therapeutics’ Path to Developing Hydroxyl Dendrimers

Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial

Science Translational Medicine

Systemic dendrimer nanotherapies for targeted suppression of choroidal inflammation and neovascularization in age-related macular degeneration

Journal of Controlled Release

Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration

AIChE

Nanoscale effects in dendrimer-mediated targeting of neuroinflammation

Science Direct

Dendrimer-Based Postnatal Therapy for Neuroinflammation and Cerebral Palsy in a Rabbit Model

Science Translational Medicine

The effect of surface functionality on cellular trafficking of dendrimers

Science Direct

Recent Posts

  • Ashvattha Therapeutics to Present Positive Phase 2 Results for Subcutaneous Migaldendranib in Retinal Vascular Disease at ARVO
  • Ashvattha Therapeutics to Present at ARVO, Retina World Congress, and AOS Annual Meeting
  • Ashvattha Therapeutics Accelerates Clinical Development Strategy with Leadership Appointment of Six Leading Retinal Specialists to Clinical Advisory Board
  • Ashvattha Presents Positive Phase 2 Data for Subcutaneous Migaldendranib at Angiogenesis 2025 Conference
  • Ashvattha to Present at Upcoming Angiogenesis, Exudation, and Degeneration 2025 and BIO CEO Conferences

Recent Comments

    Archives

    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • June 2024
    • May 2024
    • February 2024
    • January 2024
    • November 2023
    • October 2023
    • August 2023
    • May 2023
    • April 2023
    • February 2023
    • January 2023
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • September 2021
    • June 2021
    • May 2021
    • April 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • June 2020
    • May 2020

    Categories

    • In the News
    • Press Release

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Howdy, this is Creativo

    We just added a brand new Off Canvas Sidebar. You can change the content you see here by going to Appearance -> Widgets -> Off Canvas Sidebar.

    Of course you can also change the design of this sidebar by going to Appearance -> Theme Options -> Off Canvas Sidebar.

    Change everything from: background color, font color, font size, sidebar headings and more.

    © Copyright 2025 Ashvattha Therapeutics.
    • Privacy Policy
    © 2025 Ashvattha Therapeutics • Built with GeneratePress